$AVDL
AVADEL PHARMACEUTICALS PLC

2022 Q1 Form 10-Q Financial Statement

#000101247722000007 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $21.64M $11.01M
YoY Change 96.47% 39.16%
% of Gross Profit
Research & Development $6.991M $3.852M
YoY Change 81.49% -30.34%
% of Gross Profit
Depreciation & Amortization $259.0K $220.0K
YoY Change 17.73% -52.17%
% of Gross Profit
Operating Expenses $28.63M $14.86M
YoY Change 92.59% 10.57%
Operating Profit -$28.63M -$14.81M
YoY Change 93.28% 127.97%
Interest Expense -$2.017M -$1.930M
YoY Change 4.51% -39.5%
% of Operating Profit
Other Income/Expense, Net -$104.0K $0.00
YoY Change -100.0%
Pretax Income -$30.75M -$16.05M
YoY Change 91.55% 54.72%
Income Tax -$4.323M -$2.607M
% Of Pretax Income
Net Earnings -$26.42M -$13.45M
YoY Change 96.53% 1454.34%
Net Earnings / Revenue
Basic Earnings Per Share -$0.45 -$0.23
Diluted Earnings Per Share -$0.45 -$0.23
COMMON SHARES
Basic Shares Outstanding 58.82M shares 58.44M shares
Diluted Shares Outstanding 58.82M shares 58.44M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $123.5M $206.5M
YoY Change -40.2% 81.94%
Cash & Equivalents $60.87M $59.17M
Short-Term Investments $62.61M $147.3M
Other Short-Term Assets $156.0K $149.0K
YoY Change 4.7% -3.87%
Inventory
Prepaid Expenses $5.317M $4.990M
Receivables $278.0K $8.500M
Other Receivables $31.51M $22.20M
Total Short-Term Assets $160.7M $242.3M
YoY Change -33.66% 85.01%
LONG-TERM ASSETS
Property, Plant & Equipment $268.0K $344.0K
YoY Change -22.09% -27.12%
Goodwill $16.84M $16.84M
YoY Change 0.0% -8.95%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $39.64M $27.72M
YoY Change 43.0% -41.68%
Total Long-Term Assets $60.39M $50.63M
YoY Change 19.28% -34.04%
TOTAL ASSETS
Total Short-Term Assets $160.7M $242.3M
Total Long-Term Assets $60.39M $50.63M
Total Assets $221.1M $292.9M
YoY Change -24.51% 41.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.048M $2.824M
YoY Change 114.16% -58.41%
Accrued Expenses $9.432M $4.297M
YoY Change 119.5% -71.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $26.18M $0.00
YoY Change
Total Short-Term Liabilities $44.02M $9.120M
YoY Change 382.71% -71.8%
LONG-TERM LIABILITIES
Long-Term Debt $116.5M $141.5M
YoY Change -17.63% 14.77%
Other Long-Term Liabilities $3.847M $4.139M
YoY Change -7.05% -26.92%
Total Long-Term Liabilities $120.4M $145.6M
YoY Change -17.33% 12.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.02M $9.120M
Total Long-Term Liabilities $120.4M $145.6M
Total Liabilities $165.9M $156.4M
YoY Change 6.05% -10.94%
SHAREHOLDERS EQUITY
Retained Earnings -$474.2M -$383.9M
YoY Change 23.53% -2.09%
Common Stock $554.4M $542.7M
YoY Change 2.17% 9.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.23M $136.5M
YoY Change
Total Liabilities & Shareholders Equity $221.1M $292.9M
YoY Change -24.51% 41.02%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$26.42M -$13.45M
YoY Change 96.53% 1454.34%
Depreciation, Depletion And Amortization $259.0K $220.0K
YoY Change 17.73% -52.17%
Cash From Operating Activities -$34.05M -$23.41M
YoY Change 45.41% 101.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $26.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $42.25M $11.22M
YoY Change 276.57% -15.19%
Cash From Investing Activities $42.25M $11.19M
YoY Change 277.54% -15.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.009M $149.0K
YoY Change 1248.32% -99.76%
NET CHANGE
Cash From Operating Activities -$34.05M -$23.41M
Cash From Investing Activities $42.25M $11.19M
Cash From Financing Activities $2.009M $149.0K
Net Change In Cash $10.17M -$12.55M
YoY Change -181.0% -119.69%
FREE CASH FLOW
Cash From Operating Activities -$34.05M -$23.41M
Capital Expenditures $0.00 $26.00K
Free Cash Flow -$34.05M -$23.44M
YoY Change 45.25% 101.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001012477
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28626000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-14811000 USD
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
AVADEL PHARMACEUTICALS PLC
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
CY2022Q1 dei Entity File Number
EntityFileNumber
000-28508
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1341933
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10 Earlsfort Terrace
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 2
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D02 T380
CY2022Q1 dei Entity Address Country
EntityAddressCountry
IE
CY2022Q1 dei Country Region
CountryRegion
353
CY2022Q1 dei City Area Code
CityAreaCode
1
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
901-5201
CY2022Q1 dei Security12b Title
Security12bTitle
Ordinary Shares, nominal value $0.01 per share**
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59038237 shares
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6991000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3852000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21635000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11012000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
-53000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
28626000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
14811000 USD
CY2022Q1 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
1237000 USD
CY2022Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
33000 USD
CY2021Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
78000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30747000 USD
CY2021Q4 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
1225000 USD
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-137000 USD
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
610000 USD
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2017000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1929000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16052000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4323000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2607000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26424000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13445000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58824000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58443000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58824000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58443000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26424000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13445000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-185000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-718000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
330000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
55000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-917000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-537000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1102000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1255000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27526000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14700000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60873000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50708000 USD
CY2022Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
62608000 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
106513000 USD
CY2022Q1 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
2387000 USD
CY2021Q4 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
2443000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34873000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32826000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
160741000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
192490000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
268000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2410000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2652000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
16836000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
16836000 USD
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
488000 shares
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39635000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33777000 USD
CY2022Q1 us-gaap Assets
Assets
221127000 USD
CY2021Q4 us-gaap Assets
Assets
247265000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
26184000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
917000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
900000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6048000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7679000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9432000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7151000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1442000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5270000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
44023000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13445000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1255000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
116525000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
142397000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1500000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1707000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3847000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3917000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
165895000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
169021000 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
488000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
488000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
488000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59032000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59032000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58620000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58620000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
590000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
586000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553859000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
549349000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-474180000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447756000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25042000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23940000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
55232000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
78244000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221127000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
247265000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
78244000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26424000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1102000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1906000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
103000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2505000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
55232000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
162266000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
106000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
43000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1728000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
136504000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26424000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13445000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
259000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
218000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
312000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
312000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4323000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2534000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2505000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1728000 USD
CY2022Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
33000 USD
CY2021Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
78000 USD
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
702000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.141
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2607000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
561000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2058000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3736000 USD
CY2022Q1 avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
19000 USD
CY2021Q1 avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-80000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5613000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3789000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2314000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2112000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
1667000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
618000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34045000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23413000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000 USD
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
8250000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
44341000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
40736000 USD
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2090000 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
37769000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
42251000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11191000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2009000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
149000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2009000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
149000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-50000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-477000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10165000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12550000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50708000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71722000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60873000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59172000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5531000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
3234000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
63940000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
356000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1688000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
62608000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
106812000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
948000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1247000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
106513000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
304000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
11000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
790000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
68000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
26184000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
14827000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
469000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
3029000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
208000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
17856000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
677000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
191000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
116525000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
142397000 USD
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2017000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1929000 USD
CY2021Q1 avdl Coupon Interest Expense
CouponInterestExpense
1617000 USD
CY2022Q1 avdl Coupon Interest Expense
CouponInterestExpense
1617000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
312000 USD
CY2018Q1 avdl American Depository Shares Conversion Ratio
AmericanDepositorySharesConversionRatio
92.6956 Rate
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4323000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2678000 USD
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1755000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.162
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
29122000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
29097000 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5317000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3179000 USD
CY2022Q1 avdl Guarantee Current
GuaranteeCurrent
278000 USD
CY2021Q4 avdl Guarantee Current
GuaranteeCurrent
279000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
156000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
271000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34873000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32826000 USD
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
28578000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
24128000 USD
CY2022Q1 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
10082000 USD
CY2021Q4 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
8549000 USD
CY2022Q1 avdl Guarantee Noncurrent
GuaranteeNoncurrent
702000 USD
CY2021Q4 avdl Guarantee Noncurrent
GuaranteeNoncurrent
771000 USD
CY2022Q1 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
273000 USD
CY2021Q4 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
329000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39635000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
33777000 USD
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7063000 USD
CY2022Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
40000 USD
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3167000 USD
CY2022Q1 avdl Accrued Outsource Contract Costs
AccruedOutsourceContractCosts
574000 USD
CY2021Q4 avdl Accrued Outsource Contract Costs
AccruedOutsourceContractCosts
1048000 USD
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
41000 USD
CY2022Q1 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
0 USD
CY2021Q4 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
217000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9432000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7151000 USD
CY2022Q1 avdl Accrued Interest Current
AccruedInterestCurrent
1094000 USD
CY2021Q4 avdl Accrued Interest Current
AccruedInterestCurrent
4920000 USD
CY2022Q1 avdl Other Guarantor Obligations Current Carrying Value
OtherGuarantorObligationsCurrentCarryingValue
279000 USD
CY2021Q4 avdl Other Guarantor Obligations Current Carrying Value
OtherGuarantorObligationsCurrentCarryingValue
280000 USD
CY2022Q1 avdl Other Liabilities Miscellaneous Current
OtherLiabilitiesMiscellaneousCurrent
69000 USD
CY2021Q4 avdl Other Liabilities Miscellaneous Current
OtherLiabilitiesMiscellaneousCurrent
70000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1442000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5270000 USD
CY2022Q1 avdl Tax Liabilities And Other Noncurrent Liabilities
TaxLiabilitiesAndOtherNoncurrentLiabilities
3143000 USD
CY2021Q4 avdl Tax Liabilities And Other Noncurrent Liabilities
TaxLiabilitiesAndOtherNoncurrentLiabilities
3143000 USD
CY2022Q1 us-gaap Guaranty Liabilities
GuarantyLiabilities
704000 USD
CY2021Q4 us-gaap Guaranty Liabilities
GuarantyLiabilities
774000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3847000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3917000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58824000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58443000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26424000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13445000 USD
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58824000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58443000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17696000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15275000 shares
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
330000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
55000 USD
CY2022Q1 avdl Percentage Of Royalty Payable On Net Sales
PercentageOfRoyaltyPayableOnNetSales
0.15
CY2022Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
983000 USD
CY2022Q1 avdl Guarantee Asset Current Carrying Value
GuaranteeAssetCurrentCarryingValue
980000 USD

Files In Submission

Name View Source Status
0001012477-22-000007-index-headers.html Edgar Link pending
0001012477-22-000007-index.html Edgar Link pending
0001012477-22-000007.txt Edgar Link pending
0001012477-22-000007-xbrl.zip Edgar Link pending
avdl-20220331.htm Edgar Link pending
avdl-20220331.xsd Edgar Link pending
avdl-20220331_cal.xml Edgar Link unprocessable
avdl-20220331_def.xml Edgar Link unprocessable
avdl-20220331_htm.xml Edgar Link completed
avdl-20220331_lab.xml Edgar Link unprocessable
avdl-20220331_pre.xml Edgar Link unprocessable
exhibit311q12022.htm Edgar Link pending
exhibit312q12022.htm Edgar Link pending
exhibit321q12022.htm Edgar Link pending
exhibit322q12022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending